scholarly journals The endodermal passage cell – just another brick in the wall?

2021 ◽  
Author(s):  
Julia Holbein ◽  
Defeng Shen ◽  
Tonni Grube Andersen
Keyword(s):  
Viruses ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 1102
Author(s):  
Phoebe Stevenson-Leggett ◽  
Sarah Keep ◽  
Erica Bickerton

The Gammacoronavirus infectious bronchitis virus (IBV) causes a highly contagious and economically important respiratory disease in poultry. In the laboratory, most IBV strains are restricted to replication in ex vivo organ cultures or in ovo and do not replicate in cell culture, making the study of their basic virology difficult. Entry of IBV into cells is facilitated by the large glycoprotein on the surface of the virion, the spike (S) protein, comprised of S1 and S2 subunits. Previous research showed that the S2′ cleavage site is responsible for the extended tropism of the IBV Beaudette strain. This study aims to investigate whether protease treatment can extend the tropism of other IBV strains. Here we demonstrate that the addition of exogenous trypsin during IBV propagation in cell culture results in significantly increased viral titres. Using a panel of IBV strains, exhibiting varied tropisms, the effects of spike cleavage on entry and replication were assessed by serial passage cell culture in the presence of trypsin. Replication could be maintained over serial passages, indicating that the addition of exogenous protease is sufficient to overcome the barrier to infection. Mutations were identified in both S1 and S2 subunits following serial passage in cell culture. This work provides a proof of concept that exogenous proteases can remove the barrier to IBV replication in otherwise non-permissive cells, providing a platform for further study of elusive field strains and enabling sustainable vaccine production in vitro.


1994 ◽  
Vol 22 (2) ◽  
pp. 75-77
Author(s):  
V. H. Nargund ◽  
I. K. Barker ◽  
S. M. Crawford ◽  
L. Coombs ◽  
G. M. Flannigan ◽  
...  

2020 ◽  
Author(s):  
Erdem Altunel ◽  
Roham S. Roghani ◽  
Kai-Yuan Chen ◽  
So Young Kim ◽  
Shannon McCall ◽  
...  

Abstract Background: Metastatic colorectal cancer (CRC) continues to be a major health problem, and current treatments are primarily for disease control and palliation of symptoms. In this study, we developed a precision medicine strategy to discover novel therapeutics for patients with CRC. Methods: Six matched low-passage cell lines and patient-derived xenografts (PDX) were established from CRC patients undergoing resection of their cancer. High-throughput drug screens using a 119 FDA-approved oncology drug library were performed on these cell lines, which were then validated in vivo in matched PDXs. RNA-Seq analysis was then performed to identify predictors of response. Results: Our study revealed marked differences in response to standard-of-care agents across patients and pinpointed druggable pathways to treat CRC. Among these pathways co-targeting of fibroblast growth factor receptor (FGFR), SRC, platelet derived growth factor receptor (PDGFR), or vascular endothelial growth factor receptor (VEGFR) signaling was found to be an effective strategy. Molecular analyses revealed potential predictors of response to these druggable pathways. Conclusions: Our data suggests that the use of matched low-passage cell lines and PDXs is a promising strategy to identify new therapies and pathways to treat metastatic CRC.


2010 ◽  
Vol 12 (4) ◽  
pp. 391-403 ◽  
Author(s):  
Tatiana T. Sibov ◽  
Lorena F. Pavon ◽  
Daniela M. Oliveira ◽  
Luciana C. Marti ◽  
Daiane D. Guilhen ◽  
...  

2003 ◽  
Vol 71 (10) ◽  
pp. 5650-5661 ◽  
Author(s):  
Quan Lin ◽  
Yasuko Rikihisa ◽  
Norio Ohashi ◽  
Ning Zhi

ABSTRACT The human intragranulocytic bacterium Anaplasma phagocytophilum promotes variation of P44s, which are surface-exposed proteins encoded by a p44 multigene family. In the present study, the specific p44 gene expression loci in four strains of A. phagocytophilum were identified and it was determined that each consisted of four tandem genes, tr1, omp-1X, omp-1N, and p44. A putative σ70-type promoter was found upstream of tr1. The p44 genes include a central hypervariable region flanked by conserved regions. The hypervariable region sequence in the p44 expression locus was duplicated and, regardless of the expression status, conserved at another locus in both low- and high-passage cell cultures of strain NY-37. No significant differences in the hypervariable region were found when we compared p44 sequences, at the level of cDNA, within the expression locus and within other loci in the genomes of strains NY-37 and HZ. Similarly, in cDNA isolated from patients and from assorted cultures of strains NY-31, NY-36, and NY-37, hypervariable regions of 450 deduced amino acid sequences of various p44s within each strain were found to be identical, as were those of p44 sequences in the genome of strain HZ. These data suggest that variations in p44 sequences at the level of the p44 expression locus occur through unidirectional conversion of the entire (nonsegmental) p44 hypervariable region including flanking regions with a corresponding sequence copied from one of the conserved donor p44 genomic loci. The data suggest that the P44 antigenic repertoire within the hypervariable region is restricted.


2012 ◽  
Vol 25 (3) ◽  
pp. 395-397 ◽  
Author(s):  
Eleazar Vega-Saenz de Miera ◽  
Erica B. Friedman ◽  
Holly S. Greenwald ◽  
Mary A. Perle ◽  
Iman Osman

2010 ◽  
Vol 203 (1) ◽  
pp. 95
Author(s):  
M.I. Aroca ◽  
A.I. Sáez ◽  
R. Gomez ◽  
H. Navarro ◽  
P. de la Cueva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document